mizoribine has been researched along with Cytomegalic Inclusion Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Z; Liu, H; Xu, Z; Yin, W; Yiu, W | 1 |
| Akioka, K; Akutsu, N; Harada, S; Nakamura, T; Nakatani, T; Ushigome, H; Yoshimura, N | 1 |
| Hasegawa, J; Hatakeyama, S; Mieno, M; Okumi, M; Omoto, K; Shirakawa, H; Tanabe, K; Wakai, S | 1 |
| Hayashi, R; Hiromasa, T; Inoue, T; Kagawa, H; Sada, KE; Tsunashima, Y; Yamanaka, R | 1 |
| Akioka, K; Fujisawa, M; Fukuda, Y; Horimi, T; Ito, SI; Nakatani, T; Nishimura, K; Sugitani, A; Uchida, K; Ushigome, H; Yoshimura, N; Yuzawa, K | 1 |
| Matsuyama, M; Nobori, S; Okajima, H; Okamoto, M; Sakai, K; Suzuki, T; Ushigome, H; Yoshimura, N | 1 |
| Akioka, K; Fujisawa, M; Fukuda, Y; Horimi, T; Ichikawa, Y; Ito, S; Nakatani, T; Nishimura, K; Sugitani, A; Uchida, K; Yoshimura, N; Yuzawa, K | 1 |
| Abe, Y; Irie, S; Matsuoka, H; Mikami, H; Nakamura, N; Ogawara, S; Saitoh, T; Sasatomi, Y; Tanaka, M | 1 |
| Akioka, K; Nobori, S; Okamoto, M; Sakai, K; Suzuki, T; Ushigome, H; Yoshimura, N | 1 |
| Tanabe, K | 1 |
| Emoto, Y; Maeda, K; Miyazaki, T; Naoe, T; Niwa, T; Yazawa, T | 1 |
1 review(s) available for mizoribine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.
Topics: Cytomegalovirus Infections; Gastrointestinal Diseases; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Ribonucleosides | 2022 |
1 trial(s) available for mizoribine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
Topics: Adrenal Cortex Hormones; Adult; Blood Group Incompatibility; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Ribonucleosides | 2017 |
9 other study(ies) available for mizoribine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Topics: Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies; Ribonucleosides; Risk Factors; Rituximab; Tacrolimus; Tissue Donors; Treatment Outcome | 2017 |
The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Male; Middle Aged; Ribonucleosides; Tacrolimus; Young Adult | 2018 |
Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Basiliximab; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Prednisolone; Recombinant Fusion Proteins; Ribonucleosides; Viremia; Young Adult | 2016 |
The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antiviral Agents; Basiliximab; Biomarkers; Blood Group Incompatibility; Creatinine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Histocompatibility; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Japan; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Recombinant Fusion Proteins; Ribonucleosides; Rituximab; Splenectomy; Time Factors; Treatment Outcome; Young Adult | 2012 |
Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Biomarkers; BK Virus; Creatinine; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Polyomavirus Infections; Recombinant Fusion Proteins; Ribonucleosides; Treatment Outcome | 2012 |
Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation.
Topics: Adolescent; Adult; BK Virus; Child; Cytomegalovirus Infections; Female; Graft Rejection; Graft Survival; Herpes Zoster; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyomavirus Infections; Retrospective Studies; Ribonucleosides; Treatment Outcome; Young Adult | 2012 |
The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Biomarkers; Creatinine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Recombinant Fusion Proteins; Ribonucleosides; Treatment Outcome; Young Adult | 2013 |
Japanese experience of ABO-incompatible living kidney transplantation.
Topics: ABO Blood-Group System; Antigens, CD20; Azathioprine; Blood Group Incompatibility; Cytomegalovirus Infections; Histocompatibility Testing; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Plasmapheresis; Ribonucleosides; Time Factors; Treatment Outcome | 2007 |
A case of lupus nephritis showing rectal erosion with cytomegalovirus infection.
Topics: Adult; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Prednisolone; Rectal Diseases; Ribonucleosides | 1991 |